Baker Brothers Life Sciences LP - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 20, 2024, Baker Brothers Life Sciences LP's relationship to Kymera Therapeutics, Inc. (KYMR) is Director, and currently has 5,516,986 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KYMR insiders.
Data Source: SEC.
Baker Brothers Life Sciences LP - Insider Non-Derivative Transactions at KYMR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 21, 2024 | P -- (Common Stock) | 1 | 46.41 | 5516986 |